Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
about
Antiplatelet resistance in strokeNew insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolismThe safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysisPlatelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery diseaseLow dose aspirin and pregnancy: how important is aspirin resistance?Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry.Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.Effects of an aqueous extract of dangguijagyagsan on serum lipid levels and blood flow improvement in ovariectomized rats.N-substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity.Clinical importance of aspirin and clopidogrel resistanceHistorical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Aspirin resistance in off-pump coronary artery bypass grafting.Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study.Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes.Antithrombotic or anti-platelet agents in patients undergoing permanent pacemaker implantationP2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery diseaseAntiplatelet drugs in cardiological practice: established strategies and new developmentsDrug evaluation of clopidogrel in patients with ischemic stroke.Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart diseaseCombination antiplatelet agents for secondary prevention of ischemic stroke.Pharmacogenetics of cardiovascular drug therapy.Microfluidic thrombosis under multiple shear rates and antiplatelet therapy dosesUpdate on oral antiplatelet therapy: principles, problems and promises.A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes.ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease.Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.Analysis of platelet function: role of microfluidics and nanodevices.Modern antiplatelet agents in coronary artery disease.Clinical consequences of aspirin and clopidogrel resistance: an overview.An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.Recovery time of platelet function after aspirin withdrawal.Synthesis and Antiplatelet Aggregation Activity Evaluation of some 2-Aminopyrimidine and 2-Substituted-4,6-diaminopyrimidine Derivatives.Past, present, and future of anti-platelet therapy.Synthesis, Antiplatelet Activity and Cytotoxicity Assessment of Indole-Based Hydrazone Derivatives.Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.A randomized controlled trial to assess the efficacy and safety of doubling dose clopidogrel versus ticagrelor for the treatment of acute coronary syndrome in patients with CYP2C19*2 homozygotes.Stent-assisted coiling in ruptured wide-necked aneurysms: A single-center analysis.
P2860
Q22305927-9F3CA5F5-64E3-4813-8883-A09A349207BFQ26786574-CEC85B0C-0C33-4A33-8285-04AED9D3583FQ26829026-6C6DBF75-B911-4AFD-A210-7379584AB2D4Q27027247-5D7A4D7A-5F50-43C9-AE71-CB53FDD726AAQ28068597-D49DAFDE-9634-42F8-8382-8657CBDB0954Q33881728-D4A2D34E-DB39-4BEE-9C21-700626DBABAEQ34211191-BD1012BA-1A59-4DA2-B97E-76FDB5BA5688Q34224271-DA786D2B-3BA8-483C-848B-C29DDBE4B520Q34233715-FA4E62DB-A410-440B-A598-4040F1DE8A9BQ34390050-5B71DA46-2222-4AC2-A6C8-223A40CD41D1Q34536091-57C821BF-0438-49D0-9852-E890D8D68EC8Q35619792-C80C9435-738C-4CD4-8DA3-3CA710F38A0FQ35707491-8BAEB207-E5F6-4165-A92B-496D6B0E139DQ36160606-00B2A180-3A79-4C25-81BE-FCA1FB410706Q36223073-4BD8665E-731A-4811-BB69-BADF58D3BF5EQ36536498-882D1E74-66D4-4F6F-8048-611206F832A0Q36835862-AF17E8BA-9DAD-4E5F-8C6D-69E3D8D6A4F5Q36979338-36AF2501-8B1B-4A8F-B67C-BCD79F99BEC8Q37007977-4C2B5E43-9372-4184-B94A-2D87C34555AAQ37248584-B539C0DA-3B06-4DEE-9899-E4A061B8518FQ37281572-64F45479-99B3-495C-BD9A-74EFBDBB4AABQ37430401-C57BC44B-D3A7-4BAA-A005-994766ED06ECQ37431386-214E1BBB-A6EE-446A-A9B7-89297A5DA0C6Q37486605-6DD6BAFB-5F47-42C7-A5C4-5B3E20A8EEC8Q37550156-13493341-4840-491C-A59E-47DCE2D3EB50Q37567476-BBAF1E0E-DBC7-4E8F-A84A-D8699CC23270Q37749813-FB6BC613-0002-4F7E-8C19-7A5BC2E84F65Q37827566-9F76E7F2-023E-4457-886D-EAED9AACD835Q37949602-2D31F105-5FF8-4315-933B-CCF08F4A814EQ38063289-F5D49899-3F7F-41E0-A3AF-D6BFEAF46FC3Q38083817-2B6D64AC-4291-43DF-B923-4C197CF08762Q38339355-15276848-2BA1-46BE-A91B-758A3DA810F5Q39182425-21FD2F78-6100-42FE-BABE-1147C6F7CD78Q39785573-11AD7D5C-166B-4ADF-97A5-044E90ADE38DQ40109317-8FFC33D4-F7F3-431B-BE6A-CF7542CE0428Q40214640-E4F16A1C-6BAD-4C4F-92CC-171F5AA47A1AQ40597413-B2D9AF56-5F21-495B-8222-08FA130A6FC6Q41628280-05E5C116-8FB3-4869-8FFB-9B8CE6EB4BF7Q41895739-270F4F7E-39E2-4F20-BFD4-A8BAE1B5B0A2Q42384990-B4B0C8FE-8991-4A07-B0D3-022BAD58A376
P2860
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@ast
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@en
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@nl
type
label
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@ast
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@en
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@nl
prefLabel
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@ast
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@en
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@nl
P3181
P1433
P1476
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
@en
P2093
Andrew O Maree
Desmond J Fitzgerald
P304
P3181
P356
10.1161/CIRCULATIONAHA.106.675991
P407
P577
2007-04-24T00:00:00Z